> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Opens Drug Continuous Manufacturing Docket
- URL: https://www.fdaweb.com/fda-opens-drug-continuous-manufacturing-docket/
- Published: 2017-06-22T12:00:00.000Z
- Updated: 2026-09-14T22:31:06.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139004

FDA says it has established a public docket to invite discussion of issues related to adoption of continuous manufacturing by the drug industry. A *Federal Register* [notice](https://s3.amazonaws.com/public-inspection.federalregister.gov/2017-13195.pdf?ref=fdaweb.com) to be published 6/23 says that the agency agreed during a 5/7/15 workshop on the future of pharmaceutical manufacturing that interested parties could submit for agency consideration draft guidances or other materials discussing the science, technology, and best practices related to continuous manufacturing.

On 6/13/16, it says, the Engineering Research Center for Structured Organic Particulate Systems submitted to FDA an industry-coordinated best practices document on continuous manufacturing. FDA says it is interested in public comments to the new docket about the science, technology, and practices discussed in the document. FDA says it also is seeking comments on other recommendations regarding continuous manufacturing that have already been published, including results of a 5/20-21/14 symposium. “FDA invites comment on control strategy, facility, and process validation considerations for continuous monitoring of solid oral dosage forms,” the notice says.